Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model

(2015) Ilaria Paterni et al.   JOURNAL OF MEDICINAL CHEMISTRY

Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation

(2015) Abeer M. Mahmoud et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

KDM1 is a novel therapeutic target for the treatment of gliomas

(2015) Gangadhara R Sareddy et al.   Oncotarget

Immunocompetent murine models for the study of glioblastoma immunotherapy

(2014) Taemin Oh et al.   Journal of Translational Medicine

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Molecularly targeted therapies for recurrent glioblastoma: current and future targets

(2014) Darryl Lau et al.   Neurosurgical Focus

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy

(2014) C G Roehrborn et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Equol enhances tamoxifen’s anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells

(2013) Christiana Charalambous et al.   BMC CANCER

Glioblastoma and Other Malignant Gliomas

(2013) Antonio Omuro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

(2013) Mark R. Gilbert et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen Inhibits Renal Cell Carcinoma Cell Progression through Estrogen Receptor-β Activation

(2013) Cheng-Ping Yu et al.   PLoS One

Estrogen receptor-beta agonist diarylpropionitrile counteracts the estrogenic activity of estrogen receptor-alpha agonist propylpyrazole-triol in the mammary gland of ovariectomized Sprague Dawley rats

(2012) Xiaozheng Song et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Therapeutic Significance of Estrogen Receptor   Agonists in Gliomas

(2012) G. R. Sareddy et al.   MOLECULAR CANCER THERAPEUTICS

Inhibition of ERβ Induces Resistance to Cisplatin by Enhancing Rad51–Mediated DNA Repair in Human Medulloblastoma Cell Lines

(2012) Anna Wilk et al.   PLoS One

Glioblastoma: From Molecular Pathology to Targeted Treatment

(2011) Timothy F. Cloughesy et al.   Annual Review of Pathology-Mechanisms of Disease

Gene Therapy and Targeted Toxins for Glioma

(2011) Maria G. Castro et al.   CURRENT GENE THERAPY

Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis

(2011) Zinovia Kefalopoulou et al.   JOURNAL OF NEURO-ONCOLOGY

Glioblastoma survival in the United States before and during the temozolomide era

(2011) Derek R. Johnson et al.   JOURNAL OF NEURO-ONCOLOGY

Estrogen Regulates Tumor Growth Through a Nonclassical Pathway that Includes the Transcription Factors ER  and KLF5

(2011) Y. Nakajima et al.   Science Signaling

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2

(2010) Sreenivasan Paruthiyil et al.   BREAST CANCER RESEARCH AND TREATMENT

Do Steroid Hormones Play a Role in the Etiology of Glioma?

(2010) G. C. Kabat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Reproductive Factors and Exogenous Hormone Use in Relation to Risk of Glioma and Meningioma in a Large European Cohort Study

(2010) D. S. Michaud et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genome-Wide Mapping of Estrogen Receptor-β–Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1

(2010) Chunyan Zhao et al.   CANCER RESEARCH

Estrogen Receptors: Therapies Targeted to Receptor Subtypes

(2010) S Nilsson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study

(2010) Geoffrey C. Kabat et al.   INTERNATIONAL JOURNAL OF CANCER

A New Class of Estrogen Receptor Beta-Selective Activators

(2010) R. Lo et al.   MOLECULAR INTERVENTIONS

Estrogen Receptor Subtypes in Ovarian Cancer

(2010) Karen K. L. Chan et al.   OBSTETRICS AND GYNECOLOGY

Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib

(2010) Giulia Pinton et al.   PLoS One

Estrogen receptor-  activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNF  mediated

(2010) S. J. McPherson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumor Repressive Functions of Estrogen Receptor   in SW480 Colon Cancer Cells

(2009) J. Hartman et al.   CANCER RESEARCH

Estrogen increases survival in an orthotopic model of glioblastoma

(2009) Tara A. Barone et al.   JOURNAL OF NEURO-ONCOLOGY

Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors α and β: Mutual Restriction and Competitive Site Selection

(2009) Tze Howe Charn et al.   MOLECULAR ENDOCRINOLOGY